Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World August 19, 2009 Hepeng Jia	China drug scheme funds out of reach Funding through China's multi-billion yuan key drug development scheme could become harder to come by over the next five-year term of the program, according to a senior representative.
Chemistry World August 13, 2008	Chipscreen hits funding barrier for new drug Lu Xianping, president of Shenzhen -based pharma firm Chipscreen Biosciences, is close to seeing his dream of launching a new drug in China become reality
Chemistry World July 17, 2008 Hepeng Jia	Millions Raised for Drug Development China has launched its first biotech investment consortium.
Chemistry World August 21, 2013 Phillip Broadwith	Two way traffic for Chinese drug licensing Chinese companies have trailed behind their Western counterparts in developing innovative new drugs. Very few of those inventions have been considered useful enough to be licensed by western companies. However, that appears to be changing.
Chemistry World July 2010	Supporting science The Wellcome Trust is one of the largest science funding bodies in the world. Sir Mark Walport, the trust's director, tells Phillip Broadwith how it spends its money
Chemistry World September 16, 2008 Hepeng Jia	Research Initiative Targets China's Major Killer Diseases A new epidemics research initiative is targeting China's biggest killer diseases: HIV/AIDS, tuberculosis (TB) and virulent hepatitis.
The Motley Fool November 30, 2010 Brian Orelli	A Witty Response to Pharma's R&D Dilemma According to GlaxoSmithKline CEO Andrew Witty, the pharmaceutical industry is a mess. That's the basic gist of his opinion piece in The Economist.
Chemistry World May 8, 2008 Hepeng Jia	China to fast track pioneering drugs China is to speed up the approval of groundbreaking new drugs in an effort to encourage innovation in its pharmaceutical sector, a State Food and Drug Administration (SFDA) official has revealed.
Chemistry World June 24, 2011 Hepeng Jia	Pharma pollution is out of control in China Active pharmaceutical ingredients pollution problems seem to continue even after the Chinese government increased efforts to reduce environmental pollution from drug makers.
Pharmaceutical Executive December 1, 2010 Zhu Shen	China 2020: Walled In No More Pharma sets the pace for China's ambitious new innovation agenda
Chemistry World August 23, 2012 Simon Campbell	Protecting patients at all costs A new funding model is urgently required to deliver innovative medicines that meet the medical needs of the 21st century and contribute to economic growth.
Chemistry World November 10, 2015 Hepeng Jia	China's first science Nobel prize exposes anxiety on research Artemisinin saves tens of thousands of lives every year. The story of its discovery has been debated for decades in China. The awarding of the medicine Nobel prize has only served to reopen old wounds.
Chemistry World March 27, 2013 Eugene Gerden	Russian investment vehicle sets sights on innovative drugs Russian state-owned nanotechnology giant Rusnano is hoping to break into the pharmaceutical sector with sizeable investments in firms seeking to produce innovative drugs.
Chemistry World November 16, 2009 Hepeng Jia	Chinese NASDAQ brings little to chemicals industry Similar to the US NASDAQ, most of the listed firms in the Chinese GEM are technology-oriented companies. Classified by industry, electronics and pharmaceutical manufacturers are the biggest groups
Chemistry World July 20, 2010 Ned Stafford	Cash boost for EU research The European Commission has revealed details of its largest investment in research and innovation to date, announcing a funding package worth 6.4 billion ( 5.4 billion).
Chemistry World December 5, 2011 Ned Stafford	Europe plans large cash injection for research Horizon 2020 has been crafted to emphasize cooperation between academic researchers and business with the goal of 'turning scientific breakthroughs into innovative products and services'.
The Motley Fool January 31, 2011 Brian Orelli	Pharma Goes Back to School But will it produce more drugs? The pharmaceutical industry is headed back to school, with a number of large drugmakers announcing partnerships with universities.
Chemistry World May 28, 2008 Mark Peplow	Cancer research gets collaborative funding boost In an effort to crack some of the biggest problems in cancer drug discovery, Cancer Research UK has launched a unique funding program that promises to help bridge the gap between fundamental research and big pharma pipelines.
Chemistry World March 2009	Column: Undercover academic With new restrictions on Engineering and Physical Sciences Research Council (EPSRC) first grant schemes, funding may become even more elusive
Chemistry World March 2008 Janez Potocnik	Small is Beautiful The launch of the Enterprise Europe Network should help small and medium enterprises to boost innovation throughout Europe.
The Motley Fool November 30, 2010 Travis Hoium	Simcere Pharmaceutical Group Shares Popped: What You Need to Know Shares of Chinese drug company Simcere Pharmaceutical Group jumped 13% today after the company announced a fine at a company where it has controlling interest.
Chemistry World February 16, 2010 Sean Milmo	New scheme to boost bio-based chemistry The European Commission has launched an initiative to help chemical companies switch to renewable feedstocks and energy sources.
Chemistry World August 21, 2014 Eugene Gerden	Scientists claim Russia's science plan lacks ambition Scientists at the Russian Presidential Academy of National Economy and Public Administration, have called the education ministry's science and technology program for 2013 -- 2020 irrelevant.
Chemistry World December 1, 2006 Arthur Rogers	EU Approves 54 Billion Euro Science Plan The European Parliament has finally approved the Seventh Framework Research Program, which promises to distribute 54 billion euro of science funding over the next seven years.
Chemistry World March 26, 2008 Hepeng Jia	Big Funding for GM Research China is to launch a huge research program on genetically modified (GM) crops by the end of the year, according to top agricultural biotechnology advisors.
Chemistry World April 23, 2012 Eugene Gerden	Russia mulls plan for overseas study scheme The Russian government is considering funding the study of domestic students at leading foreign universities - provided they return to Russia once they have graduated.
Chemistry World July 13, 2007 Hepeng Jia	Chinese Legislation to Increase Drug Safety A long-awaited amendment to China's drug registration system is expected to discipline the country's medical sector and boost the pharmaceutical industry.
Chemistry World July 29, 2011 Ned Stafford	European Research Funding Rises 9 Per Cent Chemistry has done well in the European Commission's new funding package, up 9% from a year ago and the largest such package ever. Researchers say it is another positive step forward for the EU's innovation strategy, which will plough billions into health, energy and new materials.
Chemistry World October 2011 David Delpy	EPSRC Funding The Engineering and Physical Sciences Research Council is having to make some tough funding decisions.
Chemistry World May 2009	Column: Undercover academic Sometimes I would just like the opportunity to try something out without it being a major research project.
Chemistry World February 2009	Column: Undercover academic Late last year, the success rate for the Engineering and Physical Sciences Research Council first grant scheme was dropping alarmingly.
Chemistry World May 22, 2014 Angeli Mehta	Australian science base eroded by budget cuts Australia's research community is reeling from what have been described as short sighted and politically motivated cuts, outlined in the new conservative government's first budget.
Chemistry World May 18, 2007 Hepeng Jia	China's Battle with Fake Drugs While China's pharmaceutical industry is experiencing rapid growth, a boom in counterfeit drugs is costing human lives and eroding the public's confidence in medical products.
The Motley Fool December 27, 2007 Brian Orelli	Drugmaker Growth: The China Connection Just like other industries, the pharmaceutical industry has realized that China is a good place to find cheap labor. While reluctant to set up FDA-regulated manufacturing plants in China, other stages of drug development can be done there.
The Motley Fool May 26, 2011 Brian Orelli	Congress Sets Bad Precedent With AVANIR What happened to free markets?
Chemistry World January 14, 2010 Ned Stafford	Japan research funding safe The proposals of major cuts in researching funding triggered howls of criticism from Japanese scientists and academics, who appealed for support from the global scientific community.
The Motley Fool May 21, 2010 Brian Orelli	And You Thought Biotech Was High-Risk, High-Reward Large clinical trials make cardiovascular drugs risky, but the rewards are there, too.
Chemistry World August 20, 2013	Latvian scientists look for the exit as funding situation worsens Recent events have left hundreds of scientists in Latvia -- without research funding and looking to either leave the country or research.
Chemistry World November 18, 2010 Ned Stafford	New drug pricing rules in Germany The law was approved on 11 November and will take effect from 1 January as part of an effort to rein in exploding costs for Germany's massive public health insurance system.
Chemistry World April 4, 2012 Helen Carmichael	Canada research budget boost costs the environment Canada's researchers and environmentalists are digesting the impacts of finance minister Jim Flaherty's 2012 budget.
Chemistry World March 23, 2006 Bea Perks	Boost for Chemical Innovation A boost in innovative performance across the UK was promised at yesterday's launch of the Chemistry Innovation Knowledge Transfer Network, which plans to offer companies a single point of access to carefully selected experts and organizations.
The Motley Fool January 27, 2011 Rich Smith	What's Behind the Run-Up at Rexahn? The pharmaceutical's hot streak could soon burn up all its cash.
Chemistry World January 4, 2012 Anna Lewcock	EU membership holds research promise for Croatia As Croatia prepares to join the EU, the impact on its scientific community is likely to be mixed, with additional funding from outside counterbalanced by a disorganized national system.
BusinessWeek March 6, 2006 Bruce Einhorn	A Cancer Treatment You Can't Get Here China, with lower regulatory hurdles, is racing to a lead in gene therapy.
The Motley Fool January 28, 2010 Brian Orelli	How to Make a Billion Bucks in Biotech Drug companies and investors alike have to balance the risk and reward.
The Motley Fool September 29, 2010 Brian Orelli	Careful What You Wish For, Stem Cell Investors Investors seem to have forgotten about fundamentals.
The Motley Fool March 30, 2011 Sean Williams	China Clamps Down on Drug Manufacturers These drug manufacturers could be feeling a pinch from new Chinese price caps.
Entrepreneur January 2010 Carol Tice	Are Venture Capitalists Becoming More Adventurous? VC funding seemingly stabilizes for most of the tech sector.
Bio-IT World October 14, 2004 Robinson & Violino	Strategic Insights: Global Positioning International Economic Development for biotech companies in search of a better location or international presence, countries in Asia and Europe are offering a host of incentives, including tax credits and reduced red tape.
Chemistry World January 16, 2014 Hepeng Jia	Leading Chinese chemist jailed for embezzlement A leading environmental chemist has been jailed for embezzling money earmarked for research in China.